Gapping up
In reaction to strong earnings/guidance: BOOT +23.1%, WNC +9.7%, CEVA+8.7%, MYGN +8%, OCLR +7.6%, SNCR +6.9%, CENT +6.8%, ULTI +6.2%,NHTC +6.1%, EW +5.3%, ATW +5.3%, VJET +4.8%, ETN +4.6%, GSK +3.3%,SPR +2.9%, CMCSA +2.5%, SLAB +2.5%, BLDR +2.1%, QGEN +2%, GILD+1.6%, VIAV +1.6%, (also appoints Oleg Khaykin as CEO), ABB +1.2%,MANH +1.1%, UNM +1.1%, DOX +1%, CBG +0.8%
M&A news: MY +14.8% (to go private for $2.51 per ADS), ZAGG +4.9% (ZAGG will acquire battery case manufacturer mophie - will host a conference call Feb 2 at 6:30pm ET to discuss the proposed merger), SYT+3.4% (confirms it will be acquired by ChemChina for over $43 bln; reports better than expected earnings)
Select metals/mining stocks trading higher: VALE +4.2%, MTL +4.1%, RIO+3.6%, AUY +3.3%, FCX +2.3%, HMY +2.1%
Select oil/gas related names showing strength: OAS +4.5%, CHK +3.7%,WLL +2.8%, PBR +2.7%, STO +2%, RDS.A +1.8%, SLB +0.8%
Other news: CNAT +20% (FDA grants Conatus fast track designation for development of emricasan in Nash cirrhosis), CYTX +11.1% (announces results of Phase I clinical study; cytori cell therapy safe and potentially effective in eu phase I erectile dysfunction trial), PUK +6.3% (still checking, may just be rebounding after recent weakness), XON +5.1% (lifting premarket as shareholder Bill Miller on CNBC gives bullish view on synthetic biology company), DRWI +3.7% (confirmed consolidation of its common shares), MRVL +3.5% (Starboard Value confirms 6.7% active stake, has retained three advisors), AZN +1.4% (receives EU approval for TAGRISSO), TWO +0.9% ( announces additional 50 mln share repurchase authorization), MMM +0.7% (increases quarterly dividend to $1.11/share, an 8% increase y/y; authorizes $10 bln share buyback; 3M to retain and further invest in its Health Information Systems business)
Analyst comments: NPTN +2.4% (upgraded to Strong Buy from Outperform at Raymond James), AMAT +1.1% (added to Conviction Buy List at Goldman
In reaction to strong earnings/guidance: BOOT +23.1%, WNC +9.7%, CEVA+8.7%, MYGN +8%, OCLR +7.6%, SNCR +6.9%, CENT +6.8%, ULTI +6.2%,NHTC +6.1%, EW +5.3%, ATW +5.3%, VJET +4.8%, ETN +4.6%, GSK +3.3%,SPR +2.9%, CMCSA +2.5%, SLAB +2.5%, BLDR +2.1%, QGEN +2%, GILD+1.6%, VIAV +1.6%, (also appoints Oleg Khaykin as CEO), ABB +1.2%,MANH +1.1%, UNM +1.1%, DOX +1%, CBG +0.8%
M&A news: MY +14.8% (to go private for $2.51 per ADS), ZAGG +4.9% (ZAGG will acquire battery case manufacturer mophie - will host a conference call Feb 2 at 6:30pm ET to discuss the proposed merger), SYT+3.4% (confirms it will be acquired by ChemChina for over $43 bln; reports better than expected earnings)
Select metals/mining stocks trading higher: VALE +4.2%, MTL +4.1%, RIO+3.6%, AUY +3.3%, FCX +2.3%, HMY +2.1%
Select oil/gas related names showing strength: OAS +4.5%, CHK +3.7%,WLL +2.8%, PBR +2.7%, STO +2%, RDS.A +1.8%, SLB +0.8%
Other news: CNAT +20% (FDA grants Conatus fast track designation for development of emricasan in Nash cirrhosis), CYTX +11.1% (announces results of Phase I clinical study; cytori cell therapy safe and potentially effective in eu phase I erectile dysfunction trial), PUK +6.3% (still checking, may just be rebounding after recent weakness), XON +5.1% (lifting premarket as shareholder Bill Miller on CNBC gives bullish view on synthetic biology company), DRWI +3.7% (confirmed consolidation of its common shares), MRVL +3.5% (Starboard Value confirms 6.7% active stake, has retained three advisors), AZN +1.4% (receives EU approval for TAGRISSO), TWO +0.9% ( announces additional 50 mln share repurchase authorization), MMM +0.7% (increases quarterly dividend to $1.11/share, an 8% increase y/y; authorizes $10 bln share buyback; 3M to retain and further invest in its Health Information Systems business)
Analyst comments: NPTN +2.4% (upgraded to Strong Buy from Outperform at Raymond James), AMAT +1.1% (added to Conviction Buy List at Goldman